Close Menu

GOTHENBURG, Sweden (GenomeWeb) – Noninvasive prenatal genetic tests for detecting fetal disorders and preconception tests to assess disease recurrence risk continue to advance. At the European Human Genetics Conference here in Gothenburg yesterday, researchers presented two new noninvasive prenatal testing methods and a new way to determine recurrence risk for diseases caused by a de novo mutation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.